High-Alert Medications Independent double checks

High-Alert Medications Independent double checks

Consider a current or former practice area and select a health-related policy that is in place to assure quality and safety. Topics may include patient care policies, drug policies, security and privacy policies, or employee health policies.

In a three-to-six-page scholarly paper, address the following elements. Include a minimum of three scholarly sources, current within 5 years, to support your work. See rubric for specific, required content criteria within each section of the presentation:

Introduction

Policy Background and Purpose

Factors Influencing Policy

Policy Impact and Implications

Conclusion and Recommendations

Title page, pagination, subheadings, body of paper, citation of sources, and reference page must follow APA guidelines as found in the most current edition of the manual.

Rules of grammar, spelling, word usage, punctuation, and sentence and paragraph structure are followed and consistent with formal, scholarly writing as noted in the most current edition of the APA Manual

High-Alert Medications Independent double checks

Module 6: A Health-Related Policy

The prevalence of medication errors within healthcare systems is on the rise. These preventable threats predispose patients to multiple safety issues, including adverse drug reactions (ADRs) or death in severe cases. Therefore, incidence of medication errors in healthcare organizations is a significant performance indicator. Medication error index depicts medical facility’s values for patient’s safety, treatment outcomes, and well-being. For this reason, healthcare organizations focus on reducing incidence of medication errors reported within their system over a specific period. A significantly high percentage of medication errors reported in clinical settings is associated with human/staff mistakes (Chalasani et al., 2023). Thus, healthcare organizations focus on reducing rate of medication errors through policy change. This paper discusses, double nurse verification for high-alert medications (HAMs), which is a health-related policy that should be implemented within contemporary healthcare systems to lower high rates of medication errors.

Policy Background and Purpose

A significantly high number of inpatients are prescribed high-alert drugs, including insulin, chemotherapeutic agents, and heparin. This trend is attributed to increase in the number of inpatients seeking treatment for chronic/terminal illnesses, including cancer, diabetes Mellitus (DM), and cardiovascular disorders (CVDs). High-alert drugs are attributed to heightened risk of predisposing patients to significant harm or death when used incorrectly (van Stralen et al., 2024). However, potential ADRs can be reduced significantly if medication errors are detected early stages of drug administration process. Therefore, the proposed policy aims to ensure approximately 97% of medication errors are detected before they get to the patient.

BUY A HUMAN-WRITTEN PAPER HERE

The desired medication errors score will be achieved by ensuring double verification in highly critical clinical practices, including pediatric dosing and chemotherapy administration. Other areas that require double verification of the patient’s drug are intensive care units and insulin infusion. According to “The Institute for Safe Medication Practices” (ISMP) two clinicians should very patient’s medication independently to ensure its safety (Bertagnoli et al., 2025). Additionally, medication errors will be reduced through correct calculation of the patient’s dosage, thereby preventing ADRs that might be caused by administering high dosages. Medication errors will also be reduced by ensuring that the patient’s, drug, route, dose, formulation, and time are correct before administering drug. Strengthen accountability within the healthcare system will also play a significant role in reducing medication errors. Lastly, promote a culture of safety will lower medication errors and potential undesired treatment outcomes High-Alert Medications Independent double checks.

Factors Influencing Policy

Multiple factors have contributed to the introduction of the recommended policy, involving double verification of HAMs. The first factor is dramatic increase in number of patients using HAMs in various areas of acute care settings, including neonatal units, intensive care units (ICU), and emergency departments. For instance, insulin therapy and neuromuscular blockers are commonly prescribed to patients admitted in the ICU, emergency department, or NICU (Rochester-Eyeguokan, & Pincus, 2025). HAMs predispose these patients to significantly high risk when they are used incorrectly. Thus, these drugs must be verified by two clinicians before administering them to patients, thereby eliminating potential harm or death. Additionally, complexity of medication regimens influences introduction of double verification policy. Treatment of patients diagnosed with multiple chronic comorbidities involves complex titration protocols. These cases require double verification of the patient’s medication to ensure safe administration, thereby preventing potential safety issues.

Other influencing factors are staff’s high workload, prolonged work schedule, and pressure to provide timely patient care. Increase in number of patients seeking treatment services from the hospital acute care settings exposes staff to high workload. In some cases, clinicians work overtime to meet high demand for quality, timely, and effective patient care. As a result, healthcare providers are exposed to burnout and fatigue, making them skip the second check, which increases risk of medication error (Mert & Kersu, 2025). Therefore, double-checking policy would ensure that the patient’s medication is verified by a second clinician despite the high workload, thereby preventing potential error and related ADRs. Additionally, staff’s overconfidence necessitates implementation of the double-verification policy. In most cases, more experienced nurses feel confident; hence checking the patient’s medication once, increasing risk of medication errors. Thus, the new policy would ensure that highly-experienced nurses confirm the medication with another clinician before administering it, which would prevent potential errors and promote patient safety.

Organizational culture emphasizing on patient safety has also contributed to the adoption of double-verification policy. Contemporary healthcare systems are committed to prioritizing patient safety in various clinical practices (Alrawili et al., 2024). Therefore, double-verification process is recommended since it would ensure compliance with safety standards during drug administration despite pressure associated with high workload. High-Alert Medications Independent double checks Consequently, preventable medication errors will reduce, preventing potential adverse treatment outcomes or deaths.

The last factor is the need to comply with legal and regulatory requirements. State board of nursing standards requires healthcare institutions to comply with safety measures. The Nurse Practice Act (NPA) enforced standardized practice measures and patient safety guidelines to support high-quality care and protect the public from potential harm (Markowitz & Smith, 2024). For this reason, double verification process was adopted to protect patients from harm caused by medication errors. Moreover, this policy provides legal defensibility if medication error occurs within healthcare institutions despite compliance with all reasonable precautions, thereby preventing potential malpractice liability. Protecting patients from potential safety issues/harm through double-verification indicates compliance with accreditation requirements.

Policy Impact and Implications

The implementation of double-verification policy has positive and negative impacts. This policy would ensure compliance with patient safety standards and accreditation requirements, thereby preventing potential malpractice liabilities in the event of drug errors. This policy would also reduce healthcare system’s medication errors by ensuring a pharmaceutical regimen is double-checked by two competent clinicians before being administered to a patient. Another positive impact involves enhancing professional accountability. All healthcare providers involved in drug administration, including physicians and nurses will double check the patient’s drug to ensure correct administration route and appropriate dosage. This process will prevent potential harm/ADRs that might occur if incorrect medication or a higher dosage is administered to the patient. Lastly, double-checking patient’s medication would improve patient/family’s trust, making them satisfied with quality and safety of patient care.

However, double-checking process has some negative effects. First, this policy would result in inefficient workflow in healthcare organizations facing staff shortages since double-checking patient’s medication is time consuming. This process would also delay patient care, increasing likelihood of potential adverse treatment outcomes, particularly in critically ill emergency department patients. Lastly, inconsistent results would be reported across a healthcare organization due to variability in implementation of double-checking policy. Consequently, the new policy would be ineffective in reducing medication errors and related ADRs.

Implementing the new double-checking policy will reflect compliance with ethical standards that advocate for patient safety. This policy further implies that healthcare organizations should focus on continuous education to enhance nurses understanding of dosing and pharmacodynamics principles. Lastly, the new policy is associated with financial implications. Double-checking process aims at preventing medication errors, thereby eliminating potential litigation costs, including expenses associated with extended hospital stays.

Conclusion and Recommendations

Adopting double verification policy would improve safety among patients using HAMs by preventing potential medication errors. Consequently, additional treatment associated with ADRS would be eliminated resulting in cost-effective patient care. However, this policy would only achieve desired outcomes if it is implemented effectively across healthcare institutions. Thus, healthcare facilities should consider the possibility of getting consistent results across their departments and make necessary adjustments to ensure implementation of standardized double-check procedures High-Alert Medications Independent double checks. Additionally, the double-checking process should be monitored regularly to ensure compliance with recommended patient safety clinical practices and quality metrics.

References

Alrawili, W. G. F., Alshammari, M. H. M., Alanezi, H. S., Alrashidi, R. H. I., Al-Ruwaili, G. M. A., & Alanezi, A. L. (2024). The Importance of Patient Safety in Healthcare Institutions. 
Gland Surgery
, 
9
(2), 374-382.
https://www.diabeticstudies.org/index.php/RDS/article/view/427

Bertagnoli, S., Shastay, A., & Jew, R. K. (2025). What Does the Institute for Safe Medication Practices’ Survey Tell Us About the Impact of Shortages on Patient Safety?
The Cancer Journal
, 
31
(5), e0789.
https://journals.lww.com/journalppo/abstract/2025/09000/what_does_the_institute_for_safe_medication.12.aspx?context=latestarticles

Chalasani, S. H., Syed, J., Ramesh, M., Patil, V., & Kumar, T. P. (2023). Artificial intelligence in the field of pharmacy practice: A literature review. 
Exploratory research in clinical and social pharmacy
, 
12
, 100346.
https://www.sciencedirect.com/science/article/pii/S2667276623001270

Markowitz, S., & Smith, A. J. (2024). Nurse practitioner scope of practice and patient harm: Evidence from medical malpractice payouts and adverse action reports. 
Journal of Policy Analysis and Management
, 
43
(2), 420-445.
https://www.proquest.com/openview/3aed36787c569b5bdba81077b43a7ddc/1?pq-origsite=gscholar&cbl=18750&diss=y

Mert, S., & Kersu, Ö. (2025). Investigation of the Relationship Between Stress, Workload, Medical Error Tendency and Perceived Quality of Care in Surgical Nurses. 
Asia Pacific Journal of Health Management
, 
20
(3). 1-7.
https://journal.achsm.org.au/index.php/achsm/article/view/4641

Rochester-Eyeguokan, C. D., & Pincus, K. J. (2025). Current Recommendations for Insulin Therapy in the Hospitalized Patient. 
Critical Care Nursing Clinics
, 
37
(1), 117-131.
https://www.ccnursing.theclinics.com/article/S0899-5885(24)00039-X/abstract

van Stralen, S. A., van Eikenhorst, L., Vonk, A. S., Schutijser, B. C., & Wagner, C. (2024). Evaluating deviations and considerations in daily practice when double-checking high-risk medication administration: A qualitative study using the FRAM. 
Heliyon
, 
10
(4).
https://www.sciencedirect.com/science/article/pii/S2405844024016682
  High-Alert Medications Independent double checks